Could cannabinoids be used to help treat COVID-19?
Many of the symptoms of the disease caused by the SARS-CoV-2 virus result from excessive inflammation after the release of cytokines.
That includes acute respiratory distress syndrome (ARDS), a severe lung injury that leads to significant morbidity and mortality, especially in older people, and the most common cause of death among COVID-19 patients.
Researchers’ interest has been piqued because THC is known to bind CB2 receptors, which are found primarily on cells of the immune system. Activation of CB2 receptors by THC suppresses cytokine release.
Further research will reveal if cannabinoids such as THC can be used to treat the symptoms of COVID-19.